The introduction of nicotinamide like a nicotine alternative in e-cigarette and smokeless merchandise signifies a major regulatory obstacle for the FDA. Nicotinamide does not have nicotinic receptor agonist action and is understood to act as a sedative at high dosages6. The claims produced by Nicotine River, ECBlend, along with other distributors t